Guilin Sanjin Pharmaceutical Co Ltd (002275) — Financial Flexibility Index
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Financial Flexibility Index of 0.23x as of September 2025. Free cash flow of CN¥241.88 Million (operating CF CN¥117.62 Million minus capex CN¥124.26 Million) represents 0% of total liabilities (CN¥1.05 Billion). Check Guilin Sanjin Pharmaceutical Co Ltd (002275) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guilin Sanjin Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. See Guilin Sanjin Pharmaceutical Co Ltd (002275) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Guilin Sanjin Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Guilin Sanjin Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | CN¥670.51 Million | CN¥588.33 Million | CN¥1.22 Billion | ▼ -1.9% |
| 2023 | 0.56x | CN¥625.64 Million | CN¥549.25 Million | CN¥1.12 Billion | ▲ +8.9% |
| 2022 | 0.51x | CN¥590.93 Million | CN¥528.67 Million | CN¥1.15 Billion | ▲ +16.3% |
| 2021 | 0.44x | CN¥554.33 Million | CN¥410.24 Million | CN¥1.26 Billion | ▼ -49.3% |
| 2020 | 0.87x | CN¥803.46 Million | CN¥597.99 Million | CN¥923.27 Million | ▼ -24.8% |
| 2019 | 1.16x | CN¥694.43 Million | CN¥468.29 Million | CN¥600.18 Million | ▲ +8.1% |
| 2018 | 1.07x | CN¥641.69 Million | CN¥551.73 Million | CN¥599.47 Million | ▲ +37.1% |
| 2017 | 0.78x | CN¥449.35 Million | CN¥387.82 Million | CN¥575.65 Million | ▼ -42.4% |
| 2016 | 1.36x | CN¥602.21 Million | CN¥536.85 Million | CN¥444.26 Million | ▲ +7.9% |
| 2015 | 1.26x | CN¥523.51 Million | CN¥398.50 Million | CN¥416.59 Million | ▼ -4.3% |
| 2014 | 1.31x | CN¥607.81 Million | CN¥396.53 Million | CN¥463.07 Million | ▲ +1.8% |
| 2013 | 1.29x | CN¥627.00 Million | CN¥314.16 Million | CN¥486.11 Million | ▲ +3.4% |
| 2012 | 1.25x | CN¥508.22 Million | CN¥302.59 Million | CN¥407.26 Million | ▼ -41.8% |
| 2011 | 2.14x | CN¥467.80 Million | CN¥341.05 Million | CN¥218.18 Million | ▲ +1.3% |
| 2010 | 2.12x | CN¥383.93 Million | CN¥285.49 Million | CN¥181.47 Million | ▲ +41.2% |
| 2009 | 1.50x | CN¥417.97 Million | CN¥363.29 Million | CN¥279.00 Million | ▲ +147.1% |
| 2008 | 0.61x | CN¥229.61 Million | CN¥190.97 Million | CN¥378.65 Million | ▲ +16.5% |
| 2007 | 0.52x | CN¥181.98 Million | CN¥164.39 Million | CN¥349.58 Million | ▼ -56.9% |
| 2006 | 1.21x | CN¥246.82 Million | CN¥217.67 Million | CN¥204.48 Million | — |